Fortis Healthcare Limited informed that based on the recommendation of the Nomination and Remuneration Committee of the Company, the Board of Directors of the Company vide a circular resolution passed on March 28, 2023 has approved the appointment of Mr. Mehmet Ali Aydinlar (DIN: 10073483) and Mr. Tomo Nagahiro (DIN: 10074111), as Additional Directors (Non-Executive & Non- Independent) of the Company with effect from March 28, 2023. This is to further inform that Mr. Takeshi Saito (DIN: 08823345) and Dr. Farid Bin Mohamed Sani (DIN: 08646785) have resigned from the position of Non-Executive & Non-Independent Directors of the Company and accordingly, they have ceased to be Directors of the Company with effect from March 28, 2023 (close of business hours). Mr. Mehmet Ali Aydinlar and Mr. Tomo Nagahiro would hold office upto the date of the ensuing Annual General Meeting of the Company and liable to retire by rotation.

However, as per regulation 17(1C) of SEBI LODR, the Company shall ensure that the approval of shareholders for appointment of Mr. Mehmet Ali Aydinlar and Mr. Tomo Nagahiro on the Board of the Company is taken at the next general meeting or within 3 months, whichever is earlier. Mr. Mehmet Ali Aydinlar, aged 66 years, was appointed to the Board of IHH Healthcare Berhad (IHH) in January 2012. Mr. Mehmet Ali Aydinlar is also the Chairman of Acibadem Saglik Yatirimlari Holding A.S. (ASYH), a 90%-owned subsidiary of IHH.

He was re-designated from Executive Director to Non-Executive Director of IHH on 1 March 2019 following his cessation as the Chief Executive Officer (CEO) of ASYH. Mr. Aydinlar, after an illustrious tenure as founding CEO of ASYH, continues to serve as the Chairman of the Board of Acibadem group of companies. Mr. Aydinlar is also the Chairman of the Turkish Accredited Hospitals Association and Vice Chairman of Private Hospitals and Healthcare Institutions Association (OHSAD).

A certified public accountant-turned- entrepreneur, Mr. Aydinlar has been recognised for his extensive experience in management and involvement in the healthcare sector since 1993 and received numerous prestigious awards including but not limited to "Ernst & Young Entrepreneur of the Year, Turkiye" for the year 2018 for his entrepreneurship and contributions in healthcare industry. Being a philanthropist, Mr. Aydinlar is also the Chairman of the Board of Trustees of Acibadem University, an ambitious social responsibility undertaking initiated by Mr. Aydinlar to advance healthcare in Turkiye through education and research. Mr. Tomo Nagahiro, aged about 47 years, was appointed to the Board of IHH in February 2023.

Mr. Nagahiro was an alternate director on the Board of IHH from April 2019 to January 2023. Mr. Nagahiro has been General Manager of Strategic Planning Department in Wellness Business Unit of Mitsui & Co. Ltd. (Mitsui), overseeing Mitsui's investment in IHH since April 2019.

He has over 20 years of working experience having served in multiple divisions in Mitsui, spanning from strategic planning, business development and operations management. Preceding his current appointment, he was seconded to MIMS Pte Ltd. which is based in Singapore as the Chief Operating Officer from 2015 to 2018. Prior to this, he was seconded to Parkway Pantai Limited, a wholly-owned subsidiary of IHH, as Assistant Vice President of Strategic Planning and Business Development where he led multiple business development projects from 2013 to 2015.

Mr. Tomo Nagahiro holds Bachelor of Arts in Law from University of Tokyo, Japan; Master of Business Administration from Kellogg School of Management, Northwestern University and is U.S. Certified Public Accountant.